As an investor, deciding whether the Indogulf Cropsciences IPO is Good or Bad to invest in can often be challenging. If you are confused and worried about whether to Apply or Not the Indogulf Cropsciences IPO. Then worry not, here we are describing 10 important key points & an in-depth, detailed Indogulf Cropsciences IPO review which will help you to make the decision.
Strengths and Weaknesses of Indogulf Cropsciences IPO
Strengths:
- Over the past 30 years, they have expanded their product range and become a multi-product manufacturer of crop protection, plant nutrients, and biologicals in India.
- The company consists of network sales and dealers across 22 states and 3 Union Territories in India, and in over 34 countries worldwide.
- The company has strong experience in research and development as part of our manufacturing work.
- Indogulf Cropscience, led by experienced promoters and a capable management team, making them one of the leading crop protection products, plant nutrients biologicals in India.
Weaknesses:
- Indogulf Cropsciences may face extreme loss if they decide to change the name of the product, face quality issues, or receive negative publicity, which can lead to financial loss and cash flow.
- Failing to regularly collect payments from our customers can reduce their profits and affect the cash flow.
- Shortfall of raw materials or components can impact their price and supply of products, which can negatively impact the financial performance, cash flow, and overall condition.
- Their business relies on its manufacturing facilities, meaning there are many risks involved in the process, meaning any unexpected or Lengthy disturbance in the operations will badly impact our business, finances, and performance.
Indogulf Cropsciences IPO Details
| IPO Size | ₹200 crores |
| Offer-for-sale | 36,03,603 equity shares |
| Fresh issue | ₹160 crores |
| Price band | ₹105 to ₹111 |
| Subscription | Opens on June 26, 2025, and the closing date is June 30, 2025 |
| Purpose of IPO | Fresh Issue & Offer-for-Sale |
Indogulf Cropsciences IPO Open and closing date?
The Indogulf Cropsciences IPO opening date is June 26, 2025, and the closing date is June 30, 2025.
What is the size of the Indogulf Cropsciences IPO?
Indogulf Cropsciences planned to raise funds of around ₹200 crores via IPO. This IPO comprises a combination of a fresh issue of ₹160 crores and an offer for sale up to 36,03,603 equity shares with a face value of ₹5 each.
What are the subscription details of the Indogulf Cropsciences IPO?
The price range of Indogulf Cropsciences IPO is set as ₹105 to ₹111 per share. In this IPO, a total of 135 shares were available in 1 lot size for the minimum Retail category, and for the maximum retail category, 1755 shares in 13 lot sizes were available. For the S-HNI Minimum category, 1,890 shares were available in the 14 lot sizes. While for the B-HNI Minimum category, 9,045 shares were available in 67 lot sizes.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹14,985 and maximum investment of ₹1,94,805.
- Small HNI (S-HNI): Minimum investment of ₹2,09,790.
- Big HSI (S-HNI): A minimum investment of ₹10,03,995 is required.
What is the Indogulf Cropsciences IPO listing Date?
Indogulf Cropsciences is a Mainboard IPO shares will be listed on July 3, 2025, on the BSE (Bombay Stock Exchange) & NSE (National Stock Exchange).
What are the objectives of the Indogulf Cropsciences IPO Issue?
The proceeds raised from the fresh issue will be used towards funding the working capital requirements of our Company. Some funds will be utilized for the Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company. Some of the funds will be used for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat, Haryana. At last, use the remaining funds to support general corporate purposes.
About Indogulf Cropsciences
Founded in 1993, Indogulf Cropscience Limited, a prominent company in the manufacturing of crop protection products, plant nutrients, and biologicals in India. In 2019, the company started its business by manufacturing Spiromesifen technical with 96.5% purity, and is among the first Indian manufacturers to produce Pyrazosulfuron Ethyl technical with 97% purity. Crop protection, plant nutrients, and biologicals are the three main categories by which they operate. Both retail and institutional customers are major clients of the company, with a focus on enhancing crop yield. Samba (Jammu & Kashmir) and Nathupur (Haryana) are where their 4 manufacturing facilities are located, covering approximately twenty acres, including two sites in Nathupur and one in Barwasni, Haryana. Recently, Indogulf Cropsciences comprises a sales network across 22 states and 3 Union Territories in India with 169 business partners, 5,772 distributors, and 129 partners in 34 countries worldwide.
Indogulf Cropsciences Financials
The company reported revenue of ₹555.79 crores in 2024 against ₹552.19 crores in 2023. The company reported a profit of ₹28.23 crores in 2024 against a profit of ₹22.42 crores in 2023.
Indogulf Cropsciences IPO Promoters
The promoters of the company are Om Prakash Aggarwal, Sanjay Aggarwal, Anshu Aggarwal, and Arnav Aggarwal.
Who are the Indogulf Cropsciences IPO lead managers and registrar?
Systematix Corporate Services Limited is the lead manager of Indogulf Cropsciences, while Bigshare Services Pvt Ltd is the registrar of the company.
Should You Apply or Not for the Indogulf Cropsciences IPO?
Deciding whether to apply or not for the Indogulf Cropsciences IPO consists of reviewing its strengths, weaknesses, about, financial condition, financial goals, and risk factors. For those who don’t know, Indogulf Cropscience is one of the growing manufacturers of crop protection products, plant nutrients, and biologicals in India. They run 4 manufacturing plants and export to over 34 countries. In FY24, the company generated a revenue of ₹552 crore and a 26% rise in profit to ₹28 crore.
The company consists of 4 modern manufacturing units that produce over 400 products, robust R&D with patents. This broad presence supports both retail and institutional clients. Investors who have short-term goals can apply for this IPO. If you are looking for long-term goals, then we recommend first doing a complete background check on the company, like its financial condition, overall business, and cash flow, before investing your money in it. For more Updates or queries, please contact the IPOWatch team.
